Showing results (551-560 of 566) with videos related to

Sort By:
Pageof 57
The Journal of Clinical Endocrinology and Metabolism|April 28, 2015
LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human AdrenalLalarukh Haris Shaikh, Junhua Zhou, Ada E D Teo, et al.
Plos Genetics|May 31, 2022
Genetic characterization of outbred Sprague Dawley rats and utility for genome-wide association studiesAlexander F Gileta, Christopher J Fitzpatrick, Apurva S Chitre, et al.
Nature Communications|December 27, 2024
Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptorThomas L Williams, Grégory Verdon, Rhoda E Kuc, et al.
Experimental Neurology|September 23, 1998
Mitochondria in sporadic amyotrophic lateral sclerosisR H Swerdlow, J K Parks, D S Cassarino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2025
A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomasFaye Lewis, Mark P Ward, Feras Abu Saadeh, et al.
The Journal of Liquid Biopsy|July 11, 2026
A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patientsBrian D Henderson, Lauren McMahon, Faye Lewis, et al.
Gynecologic Oncology|January 11, 2026
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trialSe Ik Kim, Jae-Weon Kim, Janice S Kwon, et al.
European Heart Journal|January 24, 2020
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunctionThomas J Ford, David Corcoran, Sandosh Padmanabhan, et al.
NAR Cancer|December 10, 2021
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'Sophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclizationRalph P Robinson, Vincent Mascitti, Carine M Boustany-Kari, et al.
Pageof 57